Partners Innovation Fund portfolio company and PHS licensee Denali
Therapeutics was selected for FierceBiotech’s 2015 highly competitive
Fierce 15.
Most Recent Posts:
Mass General Brigham Implements DexCare to Support Care Integration and Advance Digital Health
Collaboration demonstrates Mass General Brigham’s commitment to digital transformation and enhancing patient experience SEATTLE, Oct. 31, 2022…
Innovation Grand Rounds: Clinical Innovation in Trauma: From Inception to Automation to Impact
Innovation Grand Rounds is a monthly live series with talks by innovators and executives from across the…
McKenna invited as panelist at Advamed MedTech Conference
Photo, left to right: Joseph Ferrara (moderator), Veranex Solutions; Philip Rackliffe, GE Healthcare; Erin McKenna; Kevin Boyle,…
